## Patient-Controlled Analgesia in Opioid-Tolerant Patients **Clinical Context:** This patient is opioid-tolerant due to chronic buprenorphine therapy (8 mg daily = ~32 mg morphine equivalent daily). Standard PCA parameters (1–2 mg bolus, 10-minute lockout) are inadequate for opioid-tolerant individuals and will result in inadequate postoperative analgesia and patient frustration. **Key Point:** Opioid-tolerant patients require: - **Higher bolus doses** (2–3 mg morphine or equivalent) to overcome baseline tolerance - **Extended lockout intervals** (15–20 minutes) to allow time for drug distribution and effect, while preventing overdose - **Baseline (background) infusion** (0.5–1 mg/hour) to maintain steady-state opioid levels and reduce breakthrough pain **High-Yield Principle:** The goal is to match PCA parameters to the patient's opioid requirement, not to restrict dosing arbitrarily. Inadequate dosing in tolerant patients leads to: - Severe pain and stress response - Increased sympathomimetic effects - Patient dissatisfaction and potential for self-harm or discharge against medical advice **Perioperative Management:** - **Buprenorphine continuation:** Buprenorphine should NOT be abruptly discontinued; it can be continued at reduced doses or replaced with equianalgesic morphine (accounting for its high receptor affinity) - **Morphine choice:** Morphine is appropriate; fentanyl is not routinely preferred for PCA in this context - **Monitoring:** Close observation for respiratory depression, especially with baseline infusion **Clinical Pearl:** The "lockout interval" exists to prevent overdose, not to restrict adequate analgesia. In tolerant patients, a longer interval is safer than a shorter one with inadequate bolus dosing.
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.